Gilad Almogy, Ultima Genomics CEO

Bay Area ge­nomics start­up emerges from stealth with $600M in the bank and promis­ing a '$100 genome' test

When talk­ing about ge­nomics biotechs, fi­nanc­ing rounds tend to be more on the mod­est side — an $18.5 mil­lion Se­ries A round for one, $21 mil­lion ven­ture eq­ui­ty fi­nanc­ing raise for an­oth­er, and $98 mil­lion for Al­ice Zhang’s Verge Ge­nomics Se­ries B from late last year.

But all of those pale in com­par­i­son to a new Cal­i­for­nia ge­nomics out­fit, emerg­ing from stealth Tues­day with an eye-pop­ping $600 mil­lion from a range of blue-chip in­vestors since its found­ing in 2016. The name is Ul­ti­ma Ge­nomics, led by for­mer tech ex­ec­u­tive Gi­lad Al­m­o­gy as both founder and CEO.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.